Название продукции:5-Fluoro-6-oxo-1,6-dihydropyridine-2-carbonitrile

IUPAC Name:5-fluoro-6-oxo-1,6-dihydropyridine-2-carbonitrile

CAS:1239510-82-7
Молекулярная формула:C6H3FN2O
Чистота:98%
Номер в каталоге:CM490080
Молекулярная масса:138.1

Упаковочная единица Доступно для заказа Цена ($) Количество
CM490080-100mg in stock ŮǸ
CM490080-250mg in stock ǟǟŤ
CM490080-1g in stock ǟŮij

Только для использования в НИОКР..

Форма запроса

   refresh    

Информация о продукции

Номер CAS:1239510-82-7
Молекулярная формула:C6H3FN2O
Точка плавления:-
Smiles-код:N#CC1=CC=C(F)C(N1)=O
Плотность:
Номер в каталоге:CM490080
Молекулярная масса:138.1
Точка кипения:
Номер Mdl:MFCD28768731
Хранение:Sealed in dry,Room Temperature

Category Infos

Pyridines
Pyridine is a six-membered heterocyclic compound containing one nitrogen heteroatom. Pyridine and piperidine are the most frequently occurring heterocyclic building blocks in drug molecules. According to incomplete statistics, there are currently more than 180 drugs containing pyridine or piperidine structure that have been marketed, nearly 1/5 of the drugs approved for marketing in recent years contain these two structures.
Pyridine | C5H5N | Pyridine Supplier/Distributor/Manufacturer - Chemenu
Pyridine,Pyridine Wholesale,Pyridine for Sale,Pyridine Supplier,Pyridine Distributor,Pyridine Manufacturer
Pyridine is a basic heterocyclic organic compound with the chemical formula C5H5N. It is structurally related to benzene, with one methine group (=CH−) replaced by a nitrogen atom. It is a highly flammable, weakly alkaline, water-miscible liquid with a distinctive, unpleasant fish-like smell.

Column Infos

Olutasidenib
Rigel announces publication of data on REZLIDHIA(Olutasidenib) in post-venetoclax patients with mutant IDH1 AML in Leukemia & Lymphoma.
REZLIDHIA (Olutasidenib), a potent, selective, oral, small-molecule inhibitor of mutant isocitrate dehydrogenase-1 (mIDH1), in patients with mIDH1 acute myeloid leukemia (AML) who were relapsed/refractory (R/R) to prior venetoclax-based regimens.